A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Cancer facts & figures 2002. Atlanta: American Cancer Society, 2002.

10.1056/NEJM199607113350204

10.1080/028418600750063604

10.1038/sj.bmt.1703715

10.1056/NEJM199911183412102

10.1182/blood.V98.2.492

10.1016/S1074-5521(01)00056-4

Maki CG, 1996, Cancer Res, 56, 2649

10.1101/gad.10.16.1979

10.1016/S0960-9822(00)00773-9

10.1038/sj.onc.1202189

10.1126/science.7624798

Chauhan D, 1996, Blood, 87, 1104, 10.1182/blood.V87.3.1104.bloodjournal8731104

10.1038/sj.onc.1204623

10.1074/jbc.M200360200

10.1182/blood.V99.11.4079

10.1038/sj.onc.1205664

10.1074/jbc.M109068200

10.1038/nrc952

Nix D, 2001, Prog Proc Am Soc Clin Oncol, 20, 86a

LeBlanc R, 2002, Cancer Res, 62, 4996

Hideshima T, 2001, Cancer Res, 61, 3071

Adams J, 1999, Cancer Res, 59, 2615

Sunwoo JB, 2001, Clin Cancer Res, 7, 1419

Frankel A, 2000, Clin Cancer Res, 6, 3719

Pink MM, 2002, Proc Am Assoc Cancer Res, 43, 158

Cusack JC, 2001, Cancer Res, 61, 3535

10.1006/jsre.2001.6194

10.1002/jcb.1150

Teicher BA, 1999, Clin Cancer Res, 5, 2638

10.1016/S0360-3016(01)01446-8

10.1097/00000421-200110000-00013

10.1073/pnas.202445099

10.1182/blood-2002-08-2543

10.1182/blood.V98.3.795

10.1182/blood.V99.12.4525

10.1200/JCO.2002.01.133

10.1046/j.1365-2141.1998.00930.x

Allison PD. Survival analysis using the SAS system: a practical guide. Cary, N.C.: SAS Institute, 1995.

Chamberlain GA. Heterogeneity, omitted variable bias, and duration dependence. In: Heckman JJ, Singer BS, eds. Longitudinal analysis of labor market data. Cambridge, England: Cambridge University Press, 1985.

10.1002/sim.4780030106

10.1097/00000421-199512000-00003